SG10201804944XA - Use of tenecteplase for treating acute ischemic stroke - Google Patents
Use of tenecteplase for treating acute ischemic strokeInfo
- Publication number
- SG10201804944XA SG10201804944XA SG10201804944XA SG10201804944XA SG10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA
- Authority
- SG
- Singapore
- Prior art keywords
- tenecteplase
- ischemic stroke
- treating acute
- acute ischemic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82386806P | 2006-08-29 | 2006-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201804944XA true SG10201804944XA (en) | 2018-07-30 |
Family
ID=38835003
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201501498VA SG10201501498VA (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
SG10201804944XA SG10201804944XA (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
SG2011062213A SG174753A1 (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201501498VA SG10201501498VA (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011062213A SG174753A1 (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
Country Status (22)
Country | Link |
---|---|
US (2) | US20080107641A1 (en) |
EP (1) | EP2056856B1 (en) |
JP (1) | JP5785687B2 (en) |
KR (1) | KR20090045405A (en) |
CN (1) | CN101505785A (en) |
AU (1) | AU2007290277B2 (en) |
BR (1) | BRPI0716143A2 (en) |
CA (1) | CA2661012C (en) |
CO (1) | CO6150188A2 (en) |
EA (1) | EA015573B1 (en) |
EC (1) | ECSP099178A (en) |
HK (1) | HK1131054A1 (en) |
IL (2) | IL196987A (en) |
MX (1) | MX2009001918A (en) |
MY (1) | MY163119A (en) |
NO (1) | NO342302B1 (en) |
NZ (1) | NZ574767A (en) |
SG (3) | SG10201501498VA (en) |
TW (1) | TWI439282B (en) |
UA (1) | UA97486C2 (en) |
WO (1) | WO2008027687A2 (en) |
ZA (1) | ZA200900957B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
UA95903C2 (en) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Trans carotenoids, their synthesis, formulation and uses |
ZA200900957B (en) | 2006-08-29 | 2010-05-26 | Genentech Inc | Use of tenecteplase for treating acute ischemic stroke |
JP2010524855A (en) | 2007-04-13 | 2010-07-22 | ディフュージョン・ファーマシューティカルズ・エルエルシー | Use of bipolar trans carotenoids as and in the pretreatment of peripheral vascular disease |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
RU2011130888A (en) * | 2008-12-24 | 2013-01-27 | Конинклейке Филипс Электроникс Н.В. | SYSTEM, METHOD AND DEVICE FOR INTERVENTION ON A HEART WITH A MAGNETIC RESONANT (MR) DIAGNOSTIC OF A STROKE AND ITS TREATMENT |
AU2010263245A1 (en) | 2009-06-22 | 2012-01-19 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
JP5762414B2 (en) * | 2009-08-24 | 2015-08-12 | ハフ イヤ インスティテュート | How to treat acute acoustic trauma |
AU2011262361A1 (en) | 2010-06-02 | 2013-01-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
WO2012085933A1 (en) * | 2010-12-23 | 2012-06-28 | Gennova Biopharmaceuticals Ltd. | Pharmaceutical compositions of tenecteplase |
WO2014062888A1 (en) | 2012-10-18 | 2014-04-24 | University Of South Florida | Compositions and methods for treating stroke |
CN105228688B (en) | 2013-03-15 | 2019-02-19 | 伊瑟拉医疗公司 | Vascular treatment device and method |
US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
WO2017142874A2 (en) | 2016-02-16 | 2017-08-24 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
US10220008B2 (en) | 2013-08-14 | 2019-03-05 | Stc.Unm | Treatment and prevention of stroke and other neurological disorders |
MX2017004470A (en) * | 2014-10-21 | 2017-11-20 | Gennova Biopharmaceuticals Ltd | A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase). |
KR102489034B1 (en) | 2016-03-24 | 2023-01-13 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer |
EP3573635B1 (en) * | 2017-01-24 | 2021-05-12 | Ekos Corporation | Method for the treatment of thromboembolism |
US20200138919A1 (en) * | 2017-05-16 | 2020-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute ischemic stroke |
US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
US20230068460A1 (en) * | 2020-02-04 | 2023-03-02 | The Regents Of The University Of Colorado, A Body Corporate | Prophylactic uses of annexin a2 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
ATE155816T1 (en) | 1992-06-03 | 1997-08-15 | Genentech Inc | VARIANTS OF TISSUE PLASMINOGEN ACTIVATOR WITH IMPROVED THERAPEUTIC EFFECTS |
JP2002173447A (en) * | 2000-09-29 | 2002-06-21 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical composition for treatment of cerebral embolism |
US7084118B2 (en) * | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
US20030180282A1 (en) * | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
WO2006094120A2 (en) * | 2005-03-02 | 2006-09-08 | The Regents Of The University Of California | Treatment for embolic stroke |
ZA200900957B (en) | 2006-08-29 | 2010-05-26 | Genentech Inc | Use of tenecteplase for treating acute ischemic stroke |
-
2007
- 2007-08-01 ZA ZA200900957A patent/ZA200900957B/en unknown
- 2007-08-01 CN CNA2007800318116A patent/CN101505785A/en active Pending
- 2007-08-01 AU AU2007290277A patent/AU2007290277B2/en active Active
- 2007-08-01 SG SG10201501498VA patent/SG10201501498VA/en unknown
- 2007-08-01 EA EA200970237A patent/EA015573B1/en unknown
- 2007-08-01 MY MYPI20090793A patent/MY163119A/en unknown
- 2007-08-01 JP JP2009526788A patent/JP5785687B2/en active Active
- 2007-08-01 UA UAA200902855A patent/UA97486C2/en unknown
- 2007-08-01 SG SG10201804944XA patent/SG10201804944XA/en unknown
- 2007-08-01 SG SG2011062213A patent/SG174753A1/en unknown
- 2007-08-01 EP EP07840638.6A patent/EP2056856B1/en active Active
- 2007-08-01 KR KR1020097006363A patent/KR20090045405A/en active Search and Examination
- 2007-08-01 NZ NZ574767A patent/NZ574767A/en unknown
- 2007-08-01 WO PCT/US2007/074997 patent/WO2008027687A2/en active Application Filing
- 2007-08-01 TW TW096128284A patent/TWI439282B/en active
- 2007-08-01 BR BRPI0716143-3A patent/BRPI0716143A2/en not_active Application Discontinuation
- 2007-08-01 CA CA2661012A patent/CA2661012C/en not_active Expired - Fee Related
- 2007-08-01 US US11/832,291 patent/US20080107641A1/en not_active Abandoned
- 2007-08-01 MX MX2009001918A patent/MX2009001918A/en active IP Right Grant
-
2009
- 2009-02-09 IL IL196987A patent/IL196987A/en active IP Right Grant
- 2009-02-27 CO CO09020350A patent/CO6150188A2/en unknown
- 2009-03-12 EC EC2009009178A patent/ECSP099178A/en unknown
- 2009-03-27 NO NO20091296A patent/NO342302B1/en unknown
- 2009-11-12 HK HK09110542.3A patent/HK1131054A1/en unknown
-
2011
- 2011-07-22 US US13/189,413 patent/US9023346B2/en active Active
-
2016
- 2016-10-05 IL IL248176A patent/IL248176A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200900957B (en) | Use of tenecteplase for treating acute ischemic stroke | |
IL194113A (en) | Combinations of agents for treatment of stroke | |
EP2034830A4 (en) | Methods of treating stroke | |
IL193460A0 (en) | Compounds and methods for treatment of stroke | |
ZA201004859B (en) | Use of a gamma-secretase inhibitor for treating cancer | |
EP1996182A4 (en) | Cancer treatment with gamma-secretase inhibitors | |
IL193639A0 (en) | Collagenase for treating cellulite | |
EP2264308A4 (en) | Plasma device using cylinder head | |
EP2047976A4 (en) | Steel plate-reinforcing material of type applying vibration-damping performance to steel plate | |
EP2325529A4 (en) | Cylinder head gasket | |
GB2487863B (en) | Paint-metering cylinder | |
GB0815766D0 (en) | Rotary piston and cylinder devices | |
EP2078522A4 (en) | Composition for treating allergy | |
EP2131030A4 (en) | Cylinder block | |
IL212212A0 (en) | Compound useful for treating cellulite | |
EP2249765A4 (en) | Dapsone to treat rosascea | |
GB2453625B (en) | Keys for cylinder assemblies | |
EP2306051A4 (en) | Cylinder head gasket | |
ZA200807221B (en) | Collagenase for treating cellulite | |
HK1119755A1 (en) | Brake cylinder | |
ZA200900871B (en) | Pressure cylinder | |
IL201328A0 (en) | Cylinder lock | |
TWI368170B (en) | Interruption-based concurrent profiling method | |
GB0817784D0 (en) | Hydraulic cylinder and related arrangements | |
GB2453626B (en) | Keys for cylinder assemblies |